SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
A Systematic Review of Health Economic Evaluations of Diagnostic Biomarkers
9 references·0 citing·34 second hop
A Systematic Review of Health Economic Evaluations of Diagnostic Biomarkers (2015)A Systematic Review of Health Economic Ev…Issues Surrounding the Health Economic Evaluation of Genomic Technologies (2013)Issues Surrounding the Health…Economic Incentives for Evidence Generation: Promoting an Efficient Path to Personalized Medicine (2013)Economic Incentives for Evide…Current Methodological Issues in the Economic Assessment of Personalized Medicine (2013)Current Methodological Issues…Cost-effectiveness of point-of-care C-reactive protein testing to inform antibiotic prescribing decisions (2013)Cost-effectiveness of point-o…Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement (2013)Consolidated Health Economic …Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement (2013)Consolidated Health Economic …Clinical and economic challenges facing pharmacogenomics (2012)Clinical and economic challen…A Framework for Assessing the Value of Diagnostic Imaging in the Era of Comparative Effectiveness Research (2011)A Framework for Assessing the…Cost-effectiveness Analysis in the Assessment of Diagnostic Imaging Technologies (2005)Cost-effectiveness Analysis i…A systematic review of cost-effectiveness analyses of pharmacogenomic interventions (2004)Does Comparative-Effectiveness Research Threaten Personalized Medicine? (2009)Personalized medicine: Factors influencing reimbursement (2009)Financing and Reimbursement Models for Personalised Medicine: A Systematic Review to Identify Current Models and Future Options (2022)Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers (2007)Evaluating the utility of personal genomic information (2009)Challenges in the Development and Reimbursement of Personalized Medicine—Payer and Manufacturer Perspectives and Implications for Health Economics and Outcomes Research: A Report of the ISPOR Personalized Medicine Special Interest Group (2012)Societal preferences for the return of incidental findings from clinical genomic sequencing: a discrete-choice experiment (2015)Value-Based Pricing and Reimbursement in Personalised Healthcare: Introduction to the Basic Health Economics (2017)The economic case for precision medicine (2018)Encyclopedia of Health Economics (2014)Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost‐effectiveness analysis (2002)A single European currency for EQ-5D health states (2003)Methods for the Economic Evaluation of Health Care Programmes (2005)Cost effectiveness of amoxicillin for lower respiratory tract infections in primary care: an economic evaluation accounting for the cost of antimicrobial resistance (2016)Cost-Effectiveness in Health and Medicine (1996)Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force (2013)Thresholds for the cost–effectiveness of interventions: alternative approaches (2014)Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses (2016)Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better? (2020)Principles of Good Practice for Budget Impact Analysis: Report of the ISPOR Task Force on Good Research Practices—Budget Impact Analysis (2007)Economic Evaluation for Devices and Drugs—Same or Different? (2008)Legislating against Use of Cost-Effectiveness Information (2010)Beyond Diagnostic Accuracy: The Clinical Utility of Diagnostic Tests (2012)The price of innovation: new estimates of drug development costs (2003)The evaluation of diagnostic tests: evidence on technical and diagnostic accuracy, impact on patient outcome and cost-effectiveness is needed (2007)Guidelines for authors and peer reviewers of economic submissions to the BMJ (1996)National Institute for Clinical Excellence and its value judgments (2004)Valuing the ICECAP capability index for older people (2008)Economic evaluations of personalized medicine: existing challenges and current developments (2015)Methodological Issues in Assessing the Economic Value of Next-Generation Sequencing Tests: Many Challenges and Not Enough Solutions (2018)The broader economic impact of vaccination: reviewing and appraising the strength of evidence (2015)How to prepare a systematic review of economic evaluations for informing evidence-based healthcare decisions: data extraction, risk of bias, and transferability (part 3/3) (2016)Standards of Evidence for Conducting and Reporting Economic Evaluations in Prevention Science (2018)
this work references cited by second hop

References

  • 2013Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement1,790 cited
  • 2013Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement231 cited
  • 2013Issues Surrounding the Health Economic Evaluation of Genomic Technologies108 cited
  • 2013Current Methodological Issues in the Economic Assessment of Personalized Medicine93 cited
  • 2013Cost-effectiveness of point-of-care C-reactive protein testing to inform antibiotic prescribing decisions92 cited
  • 2005Cost-effectiveness Analysis in the Assessment of Diagnostic Imaging Technologies83 cited
  • 2011A Framework for Assessing the Value of Diagnostic Imaging in the Era of Comparative Effectiveness Research79 cited
  • 2012Clinical and economic challenges facing pharmacogenomics70 cited
  • 2013Economic Incentives for Evidence Generation: Promoting an Efficient Path to Personalized Medicine51 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work